Janux
IPOLa Jolla, United States · $181.0M raised
- Headquarters
- La Jolla, California
- Employees
- 51–200
- Business Model
- B2B
- Total Funding
- $181.0M
- Last Round
- $125.0M Series BApr 2021
- Rounds
- 2
About
Janux Therapeutics develops novel T cell immunotherapies for cancer and autoimmune diseases.
Summary
Janux is a Biotech company based in La Jolla, United States. It has raised $181.0M in total across 2 rounds, most recently a $125.0M Series B round in Apr 2021. Investors include RA Capital Management, Avalon Ventures and OrbiMed.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2021
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...